Email Us

Targeted Medication Guidance for Colorectal Cancer CapitalBio

The test detects 14 genes closely related to colorectal cancer, adopts the international cutting-edge tag-sequencing technology, and is mainly used for colorectal cancer targeted drug guidance and drug resistance monitoring.

targeted medication guidance for colorectal cancer

Specification of Targeted Medication Guidance for Colorectal Cancer

Gene list:

AKT1BRAFCTNNB1EGFRERBB2FBXW7TP53
GNASKRASMAP2K1NRASPIK3CASMAD4APC


Drug list:

CetuximabPanitumumabRamucirumabAflibercept
RegorafenibBevacizumabDabrafenibVemurafenib
TrametinibDacomitinibGefitinibErlotinib
IcotinibAfatinibOsimertinib


Applicable Population of Targeted Medication Guidance for Colorectal Cancer

  • For newly diagnosed patients with colorectal cancer, treatment plans can be formulated according to molecular typing.

  • For patients in need of targeted drugs, targeted drugs can be guided based on mutation information.

  • For drug-resistant patients, drug-resistant mutations can be monitored to guide the adjustment of treatment regimens.

Specification of Targeted Medication Guidance for Colorectal Cancer

Sample typesVenous blood
TAT7 days


Products
Contact with Capitalbio
Contact Information
Your Inquiries (Expandable)
Instruments
Detection Kits/Reagents
Research Services
Biochip Design & Fabrication
Diagnostic Services
86-10-69002900
Building C, Block 88 Kechuang 6th Street, Yizhuang Biomedical Park, Beijing